Zoetis Inc. (NYSE:ZTS) Shares Bought by Sapient Capital LLC

Sapient Capital LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 212.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,859 shares of the company’s stock after buying an additional 3,305 shares during the quarter. Sapient Capital LLC’s holdings in Zoetis were worth $949,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Global Assets Advisory LLC purchased a new stake in shares of Zoetis during the 1st quarter worth approximately $8,831,000. Franklin Street Advisors Inc. NC raised its position in Zoetis by 4.3% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock valued at $20,478,000 after purchasing an additional 5,035 shares during the last quarter. Prevail Innovative Wealth Advisors LLC raised its position in Zoetis by 24.5% in the 1st quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock valued at $3,211,000 after purchasing an additional 3,738 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S raised its position in Zoetis by 58.6% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 41,931 shares of the company’s stock valued at $7,095,000 after purchasing an additional 15,491 shares during the last quarter. Finally, Duality Advisers LP raised its position in Zoetis by 43.7% in the 1st quarter. Duality Advisers LP now owns 40,641 shares of the company’s stock valued at $6,877,000 after purchasing an additional 12,359 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the subject of several research reports. BTIG Research upped their price target on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Piper Sandler boosted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. upped their price target on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Stifel Nicolaus increased their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Ten research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Zoetis currently has a consensus rating of “Buy” and an average price target of $221.44.

Zoetis Trading Up 1.4 %

NYSE ZTS opened at $192.65 on Tuesday. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The company’s 50 day moving average price is $188.43 and its 200 day moving average price is $176.42. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The firm has a market capitalization of $87.91 billion, a price-to-earnings ratio of 37.12, a PEG ratio of 2.95 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The firm had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. During the same quarter last year, the firm posted $1.41 earnings per share. Zoetis’s revenue for the quarter was up 8.3% compared to the same quarter last year. On average, sell-side analysts predict that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a yield of 0.90%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 33.14%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.